View all information regarding the medicines that are manufactured by Glaxo Smithkline Pharmaceuticals Ltd. including its generic drug name, trade name, how to use, the price, and its composition.

View all information regarding the medicines that are manufactured by Allenburys (Glaxo Smithkline Pharmaceuticals Ltd.) including its generic drug name, trade name, how to use, the price ...

Shares of GlaxoSmithKline Pharmaceuticals hit the 20 percent upper circuit at ₹2,421.30 per share on the BSE on Monday, February 17, following an impressive financial performance in the quarter ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

The merger of SmithKline Beecham Pharmaceuticals (India) Ltd into Glaxo India Limited was completed and the name of the company was changed to the present name GlaxoSmithKline Pharmaceuticals Ltd.

Elcelyx and Nimbus Pharmaceuticals, and achieved successful exits with Avidia, Morphotech, Threshold, Scioderm and Nimbus. Previously, he served as the President and CEO of Ribozyme; Senior Vice ...

Study of biology TU Munich (1982-1985), Study of molecular biology Princeton Univ. (1985-1990), PhD (1991), Max Planck Institute for Biochemistry, Martinsried (1992-1997), SmithKline Beecham ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Competing Interests: The author has been involved in clinical trials of albendazole and nitazoxanide, and has received research funding for these trials from SmithKline Beecham Pharmaceuticals and ...

Hold GlaxoSmithKline Pharmaceuticals: target of Rs 2640: ICICI Securities ICICI Securities recommended hold rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2640 in its research ...

32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...